These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31957880)

  • 1. Pharmacokinetic and pharmacodynamic analysis of (2S,3S)-sec-butylpropylacetamide (SPD) in rats and pigs-A CNS-active stereoisomer of SPD.
    Bibi D; Bialer M
    Epilepsia; 2020 Jan; 61(1):149-156. PubMed ID: 31957880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of sec-butylpropylacetamide (SPD) and valnoctamide and their individual stereoisomers in status epilepticus.
    Shekh-Ahmad T; Mawasi H; McDonough JH; Yagen B; Bialer M
    Epilepsy Behav; 2015 Aug; 49():298-302. PubMed ID: 25979572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.
    White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M
    Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic and pharmacokinetic analysis of CNS-active constitutional isomers of valnoctamide and sec-butylpropylacetamide--Amide derivatives of valproic acid.
    Mawasi H; Shekh-Ahmad T; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsy Behav; 2015 May; 46():72-8. PubMed ID: 25863940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus.
    Mawasi H; Bibi D; Shekh-Ahmad T; Shaul C; Blotnik S; Bialer M
    Mol Pharm; 2016 Jul; 13(7):2492-6. PubMed ID: 27218460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective pharmacodynamic and pharmacokinetic analysis of sec-Butylpropylacetamide (SPD), a new CNS-active derivative of valproic acid with unique activity against status epilepticus.
    Hen N; Shekh-Ahmad T; Yagen B; McDonough JH; Finnell RH; Wlodarczyk B; Bialer M
    J Med Chem; 2013 Aug; 56(16):6467-77. PubMed ID: 23879329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.
    Isoherranen N; White HS; Klein BD; Roeder M; Woodhead JH; Schurig V; Yagen B; Bialer M
    Pharm Res; 2003 Aug; 20(8):1293-301. PubMed ID: 12948028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sec-Butyl-propylacetamide (SPD) and two of its stereoisomers rapidly terminate paraoxon-induced status epilepticus in rats.
    Bar-Klein G; Swissa E; Kamintsky L; Shekh-Ahmad T; Saar-Ashkenazy R; Hubary Y; Shrot S; Stetlander L; Eisenkraft A; Friedman A; Bialer M
    Epilepsia; 2014 Dec; 55(12):1953-8. PubMed ID: 25377630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of stereoselective anticonvulsant, teratogenic, and pharmacokinetic profile of valnoctylurea (capuride): a chiral stereoisomer of valproic acid urea derivative.
    Shimshoni JA; Yagen B; Wlodarczyk B; Finnell RH; Schurig V; Bialer M
    Epilepsia; 2010 Mar; 51(3):323-32. PubMed ID: 19674061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of valnoctamide and sec-butylpropylacetamide (SPD) in terminating nerve agent-induced seizures in pediatric rats.
    Haines KM; Matson LM; Dunn EN; Ardinger CE; Lee-Stubbs R; Bibi D; McDonough JH; Bialer M
    Epilepsia; 2019 Feb; 60(2):315-321. PubMed ID: 30615805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid.
    Kaufmann D; Yagen B; Minert A; Wlodarczyk B; Finnell RH; Schurig V; Devor M; Bialer M
    Neuropharmacology; 2010 Jun; 58(8):1228-36. PubMed ID: 20230843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. sec-Butylpropylacetamide (SPD), a new amide derivative of valproic acid for the treatment of neuropathic and inflammatory pain.
    Kaufmann D; West PJ; Smith MD; Yagen B; Bialer M; Devor M; White HS; Brennan KC
    Pharmacol Res; 2017 Mar; 117():129-139. PubMed ID: 27890817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats.
    Mareš P; Kubová H; Hen N; Yagen B; Bialer M
    Epilepsy Res; 2013 Sep; 106(1-2):64-73. PubMed ID: 23815889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.
    Shekh-Ahmad T; Hen N; Yagen B; McDonough JH; Finnell RH; Wlodarczyk BJ; Bialer M
    Epilepsia; 2014 Feb; 55(2):353-61. PubMed ID: 24313671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative electrographic analysis of the effect of sec-butyl-propylacetamide on pharmacoresistant status epilepticus.
    Pouliot W; Bialer M; Hen N; Shekh-Ahmad T; Kaufmann D; Yagen B; Ricks K; Roach B; Nelson C; Dudek FE
    Neuroscience; 2013 Feb; 231():145-56. PubMed ID: 23159312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective pharmacodynamic and pharmacokinetic analysis of two chiral CNS-active carbamate derivatives of valproic acid.
    Shekh-Ahmad T; Mawasi H; McDonough JH; Finnell RH; Wlodarczyk BJ; Yavin E; Bialer M
    Epilepsia; 2014 Dec; 55(12):1944-52. PubMed ID: 25442425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
    Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
    Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sec-Butylpropylacetamide (SPD) has antimigraine properties.
    Kaufmann D; Bates EA; Yagen B; Bialer M; Saunders GH; Wilcox K; White HS; Brennan KC
    Cephalalgia; 2016 Sep; 36(10):924-35. PubMed ID: 26568161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valnoctamide and sec-butyl-propylacetamide (SPD) for acute seizures and status epilepticus.
    Shekh-Ahmad T; Hen N; McDonough JH; Yagen B; Bialer M
    Epilepsia; 2013 Sep; 54 Suppl 6(Suppl 6):99-102. PubMed ID: 24001086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of SB-204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures.
    Upton N; Blackburn TP; Campbell CA; Cooper D; Evans ML; Herdon HJ; King PD; Ray AM; Stean TO; Chan WN; Evans JM; Thompson M
    Br J Pharmacol; 1997 Aug; 121(8):1679-86. PubMed ID: 9283703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.